Post Hoc Analysis Showed CIMZIA® (Certolizumab Pegol) Resulted in Meaningful Efficacy for RA Patients with High Levels of Rheumatoid Factor (RF)

[ad_1] A post hoc analysis from the EXXELERATE Phase 4 trial showed that 65.7 percent of CIMZIA-treated patients with rheumatoid arthritis (RA) and high rheumatoid factor (RF) levels achieved low…

BREAKING: FDA issues approval for Iveric Bio avacincaptad pegol intravitreal solution for treatment of geographic atrophy

[ad_1] The biopharma company’s vacincaptad pegol intravitreal solution is formulated for the treatment of geographic atrophy (GA). Image credit: ©Viacheslav Yakobchuk – stock.adobe.com On Friday, Astellas Pharma Inc. and its…

Iveric Bio Receives U.S. FDA Approval for IZERVAY™ (avacincaptad pegol intravitreal solution), a New Treatment for Geographic Atrophy

[ad_1] IZERVAY is the only approved GA treatment with a statistically significant reduction in the rate of GA progression at the 12-month primary endpoint across two Phase 3 clinical trials…